Gamma Investing LLC Repligen Corp Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Repligen Corp stock. As of the latest transaction made, Gamma Investing LLC holds 121,896 shares of RGEN stock, worth $15.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
121,896
Previous 684
17721.05%
Holding current value
$15.5 Million
Previous $98.5 Million
99.03%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
483Shares Held
56.4MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$963 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$908 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$649 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$215 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$196 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.06B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....